Male adults
Conditions
Interventions
Consumption of the low-dose test food containing peptide materials (one packet containing three tablets) once daily for 4 weeks.
Consumption of the high-dose test food containing peptide materials (on
Sponsors
CPCC Company Limited
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1. Males aged 20 to below 50 years at the time of consent acquisition. 2. Subjects who have been performing leg strength training exercises aimed at muscle hypertrophy at least once every two weeks for more than three months (including leg extensions, leg curls, dumbbell squats, deadlifts, and bodyweight squats). 3. Subjects who can give informed consent to partake in this study, after being provided with an explanation of the protocol detail.
Exclusion criteria
Exclusion criteria: 1. Subjects who regularly consume Food for Specified Health Uses (FOSHU), Foods with Function Claims, or health supplements (including pre-workout supplements) that contain ingredients listed in the prohibited food list. 2. Subjects who plan to start consuming Food for Specified Health Uses (FOSHU), Foods with Function Claims, or health supplements (including pre-workout supplements) that contain ingredients listed in the restricted food list. 3. Subjects who are participating the other clinical trials. Subjects who participated within 4-weeks prior to the current study and/or who plan to participate the other clinical trials. 4. Subjects with excessive alcohol intake. 5. Subjects who have extremely irregular dining habits, and subjects who have midnight work or irregular shift work. 6. Subjects with previous and/or current medical history of serious diseases in heart, liver, kidney and/or digestive organs. 7. Subjects with allergies to medications and/or food. 8. Subjects who easily experience diarrhea from dairy products (including those aware of lactose intolerance). 9. Subjects who donated blood or component (200 mL) within the last 1 months. 10. Subjects who donated blood (400 mL) within the last 3 months. 11. Subjects who being collected in total of blood (1200 mL) within the last 12 months and in this study. 12. Subjects deemed unsuitable for participation in the trial by the principal investigator or sub-investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| POWER MAX | — |
Secondary
| Measure | Time frame |
|---|---|
| Physical condition questionnaire (muscle soreness, feeling of fatigue, muscle pump), Physical condition VAS (Visual Analogue Scale) questionnaire (muscle soreness, feeling of fatigue, muscle pump), Flow-Mediated Dilation (FMD), Grip strength, Knee extension strength, Thigh circumference, Body weight, Body Mass Index (BMI), Physiological tests, Hematological tests, Blood biochemistry tests, General urine analysis, Body fat percentage, Physical condition questionnaire (sensation and motivation after training) | — |
Countries
Japan
Contacts
Public ContactMasanori Numa
CPCC Company Limited Clinical Planning Department
Outcome results
None listed